[November 26, 2015]

Research and Markets: Global Nausea Pipeline Review, H2 2015 - 4 Companies & 5 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/49s97p/nausea_pipeline) has announced the addition of the "Nausea - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Nausea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It als reviews key players involved in the therapeutic development for Nausea and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

• Aequus Pharmaceuticals Inc.
• Conrig Pharma ApS
• Epiomed Therapeutics, Inc.
• InteguRx Therapeutics, LLC

Drug Profiles

• (doxylamine + pyridoxine)
• ETI (News - Alert)-385
• granisetron hydrochloride SR
• ondansetron hydrochloride
• ST-016

For more information visit http://www.researchandmarkets.com/research/49s97p/nausea_pipeline

View source version on businesswire.com: http://www.businesswire.com/news/home/20151126005490/en/

[ Back To TMCnet.com's Homepage ]